Banque Cantonale Vaudoise Abiomed Inc Transaction History

Banque Cantonale Vaudoise

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$310.19 - $376.2 $43,426 - $52,668	-140 Reduced 12.28%	1,000 $326,000
Q2 2021 Aug 11, 2021	BUY	$262.71 - $351.17 $36,779 - $49,163	140 Added 14.0%	1,140 $356,000
Q1 2021 May 11, 2021	SELL	$285.92 - $355.13 $28,592 - $35,513	-100 Reduced 9.09%	1,000 $319,000
Q4 2020 Feb 05, 2021	SELL	$251.88 - $324.2 $302,256 - $389,040	-1,200 Reduced 52.17%	1,100 $356,000
Q3 2020 Oct 30, 2020	BUY	$255.22 - $317.0 $102,088 - $126,800	400 Added 21.05%	2,300 $637,000
Q2 2020 Jul 22, 2020	SELL	$141.4 - $257.09 $169,680 - $308,507	-1,200 Reduced 38.71%	1,900 $458,000
Q1 2020 May 14, 2020	BUY	$130.51 - $196.01 $300,173 - $450,823	2,300 Added 287.5%	3,100 $450,000
Q4 2019 Feb 10, 2020	BUY	$159.31 - $223.54 $127,448 - $178,832	800 New	800 $136,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.